Helpline: 1‑267‑338‑4262 | helpline@genetic.org
AXYS - The Association for X&Y Chromosome Variations
Helpline: 1‑267‑338‑4262 | info@genetic.org

Search results for: 🏚️🧠⚯ www.DoctorFox.xyz ⚯🧠🏚️ Site de commande en ligne de ed supplier europe Cialis pas chers en pharmacie 91

Tremor in 48,XXYY Syndrome

Article Title: Tremor in 48,XXYY Syndrome

Authors: Nicole Tartaglia, MD, Mariya Borodyanskya, BA and Deborah A. Hall, MD, PhD

Date of Publication: October 15, 2009

“The 48,XXYY syndrome is a form of sex chromosome aneuploidy presenting in 1:18,000 males. Tremor has been previously reported in 47,XXY and 47,XYY syndromes, but has not been well described in 48,XXYY syndrome. Ten males with 48,XXYY syndrome had a standardized neurological examination and videotaping, which included the Clinical Rating Scale for Tremor and the International Cooperative Ataxia Rating Scale. All 10 cases had postural and kinetic tremor on physical examination. Other findings included mild gait ataxia, dysarthria, and nystagmus. Three cases are reviewed. Tremor is a common finding in children and young adults with 48,XXYY syndrome. Dosage alteration of genes on the sex chromosomes may be involved in the pathogenesis of this tremor. Karyotyping should be considered in individuals presenting with tremor and a history of developmental delay, learning disabilities, tall stature, or micro-orchidism.”

Read more

2018-09-02T16:44:40-04:00Categories: 48,XXYY|

Research Opportunities for X&Y Chromosome Variations

Research Opportunities for X&Y Chromosome Variations

family

Print This Page

AXYS is pleased to provide the following list of studies that our community members may consider joining. All listed studies have been approved by an Institutional Review Board (IRB) and meet guidelines established by AXYS regarding relevancy to X&Y variations. AXYS takes no position and makes no claims as to the potential benefits of the studies, and cannot be responsible for any outcomes or unintended side effects. If interested in participating, please use the contact information in the listing.


Name/Purpose of Study: TREAT-KS: An Evaluation of a Testosterone Replacement Therapy Patient Education Material for Adolescents and Young Adults with Klinefelter Syndrome

X and Y variations being studied: 47,XXY

Genders being studied: All

Age Range: 14-25 years

Other eligibility requirements: Individuals with mosaic KS (46,XY/47,XYY) are eligible but higher order X aneuploidies (i.e., 48,XXXY and 49,XXXXY) are not. Individuals must be able to read English.

Travel required: No

Sponsoring Institution: Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University

Principal Investigator(s): Allison Weisman, MS, CGC

Link to a more detailed description: https://redcap.luriechildrens.org/surveys/?s=YLMNN8EYAJCWWEPK

Primary funding source(s): Northwestern University Graduate Program in Genetic Counseling

Primary Contact: Sofia Marrufo, sofia.marrufo@northwestern.edu

Date Posted: May 15, 2025

Study Flyer


Name/Purpose of Study: GALAXY Registry: Generating Advancements in Longitudinal Analysis in X&Y Chromosome Variations

X and Y variations being studied: All

Genders being studied: All

Age Range: All

Other eligibility requirements: Genetic test results confirming X&Y variation

Travel required: No

Sponsoring Institution: University of Colorado

Principal Investigator(s): Shanlee Davis, MD, PhD

Link to a more detailed description: www.galaxyregistry.org

Primary funding source(s): AXYS, Living with XXY, University of Colorado

Primary Contact: galaxy@ucdenver.edu

Date Posted: May 8, 2025


Name/Purpose of Study: The Voices Study: Learning from youth about their care needs and priorities

X and Y variations being studied: Klinefelter syndrome (47,XXY)

Genders being studied: No restrictions based upon gender

Age Range: 11-21 years

Other eligibility requirements: Diagnosis of 47,XXY/Klinefelter syndrome, must be able to understand basic sentences and questions in English, access to a web-capable device, access to an internet connection

Travel required: No

Sponsoring Institution: Children’s National Hospital

Principal Investigator(s):

Link to a more detailed description: Study flyer

Primary funding source(s): National Institutes of Health (NIH)

Primary Contact: Alejandro Todd, datodd@childrensnational.org, 301-765-5573

Date Posted: November 12, 2024


Name/Purpose of Study: Physical Fitness and Quality of Life Assessment in Children and Adolescents with Klinefelter Syndrome

X and Y variations being studied: Klinefelter syndrome (47,XXY)

Genders being studied: Male

Age Range: 10-17 years

Other eligibility requirements: Patients must know their Klinefelter syndrome diagnosis, speak English, and be able to travel to Chicago, if live out of state. Participation in all days is encouraged but not required.

Travel required: Yes

Sponsoring Institution: Ann & Robert H. Lurie Children’s Hospital of Chicago

Principal Investigator(s): Courtney Finlayson, MD

Link to a more detailed description: Study flyer | Register for the study

Primary funding source(s): Ann & Robert H. Lurie Children’s Hospital of Chicago

Primary Contact: Danielle Lee, Leeda@luriechildrens.org, 312-227-6203

Date Posted: August 7, 2024 (updated June 5, 2025)


Name/Purpose of Study: Exploring the Transition From Pediatric to Adult Care in Patients with Klinefelter Syndrome

X and Y variations being studied: Klinefelter syndrome (47,XXY)

Genders being studied: No restrictions based upon gender

Age Range: 14-26 years

Other eligibility requirements: Diagnosis of 47,XXY/Klinefelter syndrome. Participants must be able to speak English.

Travel required: No. Study involves an online survey and an optional post-survey interview, also conducted remotely.

Sponsoring Institution: University of Colorado

Principal Investigator(s): Susan Howell, MBA, MS, CGC

Link to a more detailed description: Study flyer

Primary funding source(s): University of Colorado

Primary Contact: Aaron Holben, aaron.holben@cuanschutz.edu, 360-635-7001

Link to the online survey

Date Posted: December 7, 2023


Name/Purpose of Study: The ASSERT: All StakeholderS Engaged in Research Together project seeks to engage people on the autism spectrum, with Down syndrome, or with other intellectual or developmental disabilities (IDD) along with caregivers, clinicians, and researchers. The goal is to build an online learning community where these stakeholders learn about research together in a way that is collaborative and multidirectional (all learners gain knowledge from each other).

X and Y variations being studied: All

Genders being studied: All

Age Range: 18+

Other eligibility requirements: People ages 18 or older on the autism spectrum, with Down syndrome, or with IDD; caregivers (including adult siblings) of a person on the autism spectrum, with Down syndrome, or with IDD; clinicians who care for those on the autism spectrum, with Down syndrome, or with IDD; and researchers engaged in research focused on the autism spectrum, Down syndrome, or IDD. Must have internet access and a web-capable device.

Travel required: No

Sponsoring Institution: Vanderbilt University

Principal Investigator(s): Beth Malow, MD, MS

Link to a more detailed description: vkc.vumc.org/studyfinder/552 | Study Brochure

Primary funding source(s): Vanderbilt University

Primary Contact: assert@vumc.org

Date Posted: May 13, 2022


Name of Study: MyPaTH Story Booth

X and Y variations being studied: All

Genders being studied: All

Age Range: 18+ years

Other eligibility requirements: Able to read and understand English

Travel required: No, interview by phone

Sponsoring Institution: Patient-Centered Outcomes Research Institute

Principal Investigator(s): Kathleen McTigue, MD, University of Pittsburgh, UPMC, PaTH CDRN

Link to a more detailed description: www.pathnetwork.org/research/MyPaTH_story_booth.html | Study Flyer

Primary funding source(s): Patient-Centered Outcomes Research Institute

Primary Contact: mystory@pitt.edu412-208-5241

Date Posted: February 19, 2020


Name of Study: National Institutes of Health (NIH) Behavioral, Cognitive, and Brain Imaging Study for Girls and Young Women with Trisomy X (2 day study)

X and Y variations being studied: Trisomy X

Genders being studied: Female

Age Range: 5 to 25 years

Other eligibility requirements: 

Travel required: Yes. 2 day study near Washington, DC. Flights and lodging are provided, along with a meal allowance and participant payment.

Sponsoring Institution: National Institutes of Health (NIH)

Principal Investigator(s): Dr. Armin Raznahan

Link to a more detailed description: Children w/ X & Y Chromosome Variations | Adults w/ X & Y Chromosome Variations | Study Flyer

Primary funding source(s): National Institutes of Health Intramural Research Program

Primary Contact: Bobby Das at dasb@mail.nih.gov or 301-435-4516

Date Posted: January 15, 2020

2025-06-05T15:25:04-04:00

Other Variations

48,XXXX (Tetrasomy X)

rarediseases.info.nih.gov/diseases/7754/tetrasomy-x

 

48,XYYY

rarediseases.info.nih.gov/diseases/11985/48xyyy

www.ncbi.nlm.nih.gov/pmc/articles/PMC5771943/

 

49,XXXXX (Pentasomy X)

rarediseases.org/rare-diseases/penta-x-syndrome/

rarediseases.info.nih.gov/diseases/5678/49xxxxx-syndrome

 

49,XXXXY

48,XXYY, 48,XXXY and 49,XXXXY Syndromes: Not Just Variants of Klinefelter Syndrome by Dr. Nicole Tartaglia et al.

groups.yahoo.com/neo/groups/49variant/info

 

49,XYYYY

www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=99330


More Tetrasomy and Pentasomy information and support coming soon.

2022-09-14T14:26:32-04:00

Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome

Article Title: Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome

Authors: Shanlee Davis, MD; Susan Howell, MS, CGC, MBA; Rebecca Wilson, PsyDc; Tanea Tanda, BS; Judy Ross, MD; Philip Zeitler, MD, PhD; Nicole Tartaglia, MD, MS

Date of Publication: August 2016

“In summary, KS is a common but underdiagnosed genetic condition with significant phenotypic variability in childhood. The pediatrician needs to be aware of the increased risk for neurodevelopmental, psychological, and medical conditions that are associated with an additional X-chromosome. Over the next decade, we anticipate a sharp increase in diagnoses rates with advances in genetics, particularly prenatal and neonatal diagnoses. In the United States, more multidisciplinary clinics are being established to provide comprehensive care for children and adults with KS and other sex chromosome variations. More research is needed to further define the natural history of KS in infancy and childhood with these unbiased populations, as well as understand genetic and environmental contributors to phenotypic variability and determine best practice screening and management guidelines for boys with KS.”

Read more

2018-08-23T12:27:09-04:00Categories: 47,XXY (Klinefelter)|

Klinefelter syndrome: current management and research challenges

Article Title: The Klinefelter syndrome: current management and research challenges

Authors: E. Nieschlag, A. Ferlin, C. H. Gravholt, J. Gromoll, B. Kohler, H. Lejeune, A. D. Rogol and J. Wistuba

Date of Publication: April 1, 2016

“Following the 1st International Workshop on the Klinefelter Syndrome in 2010 (Juul et al., 2011), the 2nd IWKS took place in Munster, Germany from March 10 to 12, 2016 and was organized by the Centre of Reproductive Medicine and Andrology of the University of Munster. During the program, talks were presented by leading researchers in the field followed by lively discussions among the 120 participants.”

Read More

2018-09-02T16:18:42-04:00Categories: 47,XXY (Klinefelter)|

Gender and Sex Discussion

Article Title: Sex Redefined

Author: Claire Ainsworth

Date of Publication: February 18, 2015

“The idea of two sexes is simplistic. Biologists now think there is a wider spectrum than that.

As a clinical geneticist, Paul James is accustomed to discussing some of the most delicate issues with his patients. But in early 2010, he found himself having a particularly awkward conversation about sex.

A 46-year-old pregnant woman had visited his clinic at the Royal Melbourne Hospital in Australia to hear the results of an amniocentesis test to screen her baby’s chromosomes for abnormalities. The baby was fine — but follow-up tests had revealed something astonishing about the mother. Her body was built of cells from two individuals, probably from twin embryos that had merged in her own mother’s womb. And there was more. One set of cells carried two X chromosomes, the complement that typically makes a person female; the other had an X and a Y. Halfway through her fifth decade and pregnant with her third child, the woman learned for the first time that a large part of her body was chromosomally male.”

Read more

2018-09-04T11:42:04-04:00Categories: All Variations|

Gender and Sex Commentary

Article Title: Sex Isn’t Chromosomes: The Story of a Century of Misconceptions about X & Y

Author: Ian Steadman

Date of Publication: February 23, 2015

“The influence of the XX/XY model of chromosomal sex has been profound over the last century, but it’s founded on faulty premises and responsible for encouraging reductive, essentialist thinking. While the scientific world has moved on, its popular appeal remains.”

Read more

2018-09-04T11:51:54-04:00Categories: All Variations|

Testis Development and Reproductive Options in Males with Klinefelter Syndrome

Article Title: Testis Development and Reproductive Options in Males with Klinefelter Syndrome

Authors: Shanlee M. Davis, MD; Alan D. Rogol, MD, PhD; Judith L. Ross, MD

Date of Publication: September 28, 2015

“Klinefelter syndrome (KS) is the leading genetic cause of primary hypogonadism and infertility in men. The clinical phenotype has expanded beyond the original description of infertility, small testes and gynecomastia. Animal models, epidemiological studies, and clinical research of males with KS throughout the lifespan have allowed us to better characterize the variable phenotype of this condition. This review will provide an overview on what is known of the epidemiology, clinical features, and pathophysiology of KS, followed by a more focused discussion of testicular development and the clinical management of hypogonadism and fertility in men with KS.”

Read more

2018-09-04T12:10:27-04:00Categories: 47,XXY (Klinefelter)|

Terms Of Use

AGREEMENT BETWEEN USER AND AXYS

The AXYS Web Site is comprised of various Web pages operated by AXYS.

The AXYS Web Site is offered to you conditioned on your acceptance without modification of the terms, conditions, and notices contained herein. Your use of the AXYS Web Site constitutes your agreement to all such terms, conditions, and notices.

MODIFICATION OF THESE TERMS OF USE

AXYS reserves the right to change the terms, conditions, and notices under which the AXYS Web Site is offered, including but not limited to the charges associated with the use of the AXYS Web Site.

LINKS TO THIRD PARTY SITES

The AXYS Web Site may contain links to other Web Sites (“Linked Sites”). The Linked Sites are not under the control of AXYS and AXYS is not responsible for the contents of any Linked Site, including without limitation any link contained in a Linked Site, or any changes or updates to a Linked Site. AXYS is not responsible for webcasting or any other form of transmission received from any Linked Site. AXYS is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by AXYS of the site or any association with its operators.

NO UNLAWFUL OR PROHIBITED USE

As a condition of your use of the AXYS Web Site, you warrant to AXYS that you will not use the AXYS Web Site for any purpose that is unlawful or prohibited by these terms, conditions, and notices. You may not use the AXYS Web Site in any manner which could damage, disable, overburden, or impair the AXYS Web Site or interfere with any other party’s use and enjoyment of the AXYS Web Site. You may not obtain or attempt to obtain any materials or information through any means not intentionally made available or provided for through the AXYS Web Sites.

USE OF COMMUNICATION SERVICES

The AXYS Web Site may contain bulletin board services, chat areas, news groups, forums, communities, personal web pages, calendars, and/or other message or communication facilities designed to enable you to communicate with the public at large or with a group (collectively, “Communication Services”), you agree to use the Communication Services only to post, send and receive messages and material that are proper and related to the particular Communication Service. By way of example, and not as a limitation, you agree that when using a Communication Service, you will not:

  • Defame, abuse, harass, stalk, threaten or otherwise violate the legal rights (such as rights of privacy and publicity) of others.
  • Publish, post, upload, distribute or disseminate any inappropriate, profane, defamatory, infringing, obscene, indecent or unlawful topic, name, material or information.
  • Upload files that contain software or other material protected by intellectual property laws (or by rights of privacy of publicity) unless you own or control the rights thereto or have received all necessary consents.
  • Upload files that contain viruses, corrupted files, or any other similar software or programs that may damage the operation of another’s computer.
  • Advertise or offer to sell or buy any goods or services for any business purpose, unless such Communication Service specifically allows such messages.
  • Conduct or forward surveys, contests, pyramid schemes or chain letters.
  • Download any file posted by another user of a Communication Service that you know, or reasonably should know, cannot be legally distributed in such manner.
  • Falsify or delete any author attributions, legal or other proper notices or proprietary designations or labels of the origin or source of software or other material contained in a file that is uploaded.
  • Restrict or inhibit any other user from using and enjoying the Communication Services.
  • Violate any code of conduct or other guidelines which may be applicable for any particular Communication Service.
  • Harvest or otherwise collect information about others, including e-mail addresses, without their consent.
  • Violate any applicable laws or regulations.

AXYS has no obligation to monitor the Communication Services. However, AXYS reserves the right to review materials posted to a Communication Service and to remove any materials in its sole discretion. AXYS reserves the right to terminate your access to any or all of the Communication Services at any time without notice for any reason whatsoever.

AXYS reserves the right at all times to disclose any information as necessary to satisfy any applicable law, regulation, legal process or governmental request, or to edit, refuse to post or to remove any information or materials, in whole or in part, in AXYS’s sole discretion.

Always use caution when giving out any personally identifying information about yourself or your children in any Communication Service. AXYS does not control or endorse the content, messages or information found in any Communication Service and, therefore, AXYS specifically disclaims any liability with regard to the Communication Services and any actions resulting from your participation in any Communication Service. Managers and hosts are not authorized AXYS spokespersons, and their views do not necessarily reflect those of AXYS.

Materials uploaded to a Communication Service may be subject to posted limitations on usage, reproduction and/or dissemination. You are responsible for adhering to such limitations if you download the materials.

MATERIALS PROVIDED TO AXYS OR POSTED AT ANY AXYS WEB SITE

AXYS does not claim ownership of the materials you provide to AXYS (including feedback and suggestions) or post, upload, input or submit to any AXYS Web Site or its associated services (collectively “Submissions”). However, by posting, uploading, inputting, providing or submitting your Submission you are granting AXYS, its affiliated companies and necessary sublicensees permission to use your Submission in connection with the operation of their Internet businesses including, without limitation, the rights to: copy, distribute, transmit, publicly display, publicly perform, reproduce, edit, translate and reformat your Submission; and to publish your name in connection with your Submission.

No compensation will be paid with respect to the use of your Submission, as provided herein. AXYS is under no obligation to post or use any Submission you may provide and may remove any Submission at any time in AXYS’s sole discretion.

By posting, uploading, inputting, providing or submitting your Submission you warrant and represent that you own or otherwise control all of the rights to your Submission as described in this section including, without limitation, all the rights necessary for you to provide, post, upload, input or submit the Submissions.

LIABILITY DISCLAIMER

THE INFORMATION, SOFTWARE, PRODUCTS, AND SERVICES INCLUDED IN OR AVAILABLE THROUGH THE AXYS WEB SITE MAY INCLUDE INACCURACIES OR TYPOGRAPHICAL ERRORS. CHANGES ARE PERIODICALLY ADDED TO THE INFORMATION HEREIN. AXYS AND/OR ITS SUPPLIERS MAY MAKE IMPROVEMENTS AND/OR CHANGES IN THE AXYS WEB SITE AT ANY TIME. ADVICE RECEIVED VIA THE AXYS WEB SITE SHOULD NOT BE RELIED UPON FOR PERSONAL, MEDICAL, LEGAL OR FINANCIAL DECISIONS AND YOU SHOULD CONSULT AN APPROPRIATE PROFESSIONAL FOR SPECIFIC ADVICE TAILORED TO YOUR SITUATION.

AXYS AND/OR ITS SUPPLIERS MAKE NO REPRESENTATIONS ABOUT THE SUITABILITY, RELIABILITY, AVAILABILITY, TIMELINESS, AND ACCURACY OF THE INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS CONTAINED ON THE AXYS WEB SITE FOR ANY PURPOSE. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, ALL SUCH INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS ARE PROVIDED “AS IS” WITHOUT WARRANTY OR CONDITION OF ANY KIND. AXYS AND/OR ITS SUPPLIERS HEREBY DISCLAIM ALL WARRANTIES AND CONDITIONS WITH REGARD TO THIS INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS, INCLUDING ALL IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT.

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL AXYS AND/OR ITS SUPPLIERS BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF USE, DATA OR PROFITS, ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE USE OR PERFORMANCE OF THE AXYS WEB SITE, WITH THE DELAY OR INABILITY TO USE THE AXYS WEB SITE OR RELATED SERVICES, THE PROVISION OF OR FAILURE TO PROVIDE SERVICES, OR FOR ANY INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS OBTAINED THROUGH THE AXYS WEB SITE, OR OTHERWISE ARISING OUT OF THE USE OF THE AXYS WEB SITE, WHETHER BASED ON CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY OR OTHERWISE, EVEN IF AXYS OR ANY OF ITS SUPPLIERS HAS BEEN ADVISED OF THE POSSIBILITY OF DAMAGES. BECAUSE SOME STATES/JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU. IF YOU ARE DISSATISFIED WITH ANY PORTION OF THE AXYS WEB SITE, OR WITH ANY OF THESE TERMS OF USE, YOUR SOLE AND EXCLUSIVE REMEDY IS TO DISCONTINUE USING THE AXYS WEB SITE.

SERVICE CONTACT :

System@genetic.org

TERMINATION/ACCESS RESTRICTION

AXYS reserves the right, in its sole discretion, to terminate your access to the AXYS Web Site and the related services or any portion thereof at any time, without notice. GENERAL To the maximum extent permitted by law, this agreement is governed by the laws of the State of Washington, U.S.A. and you hereby consent to the exclusive jurisdiction and venue of courts in San Mateo County, California, U.S.A. in all disputes arising out of or relating to the use of the AXYS Web Site. Use of the AXYS Web Site is unauthorized in any jurisdiction that does not give effect to all provisions of these terms and conditions, including without limitation this paragraph. You agree that no joint venture, partnership, employment, or agency relationship exists between you and AXYS as a result of this agreement or use of the AXYS Web Site. AXYS’s performance of this agreement is subject to existing laws and legal process, and nothing contained in this agreement is in derogation of AXYS’s right to comply with governmental, court and law enforcement requests or requirements relating to your use of the AXYS Web Site or information provided to or gathered by AXYS with respect to such use. If any part of this agreement is determined to be invalid or unenforceable pursuant to applicable law including, but not limited to, the warranty disclaimers and liability limitations set forth above, then the invalid or unenforceable provision will be deemed superseded by a valid, enforceable provision that most closely matches the intent of the original provision and the remainder of the agreement shall continue in effect. Unless otherwise specified herein, this agreement constitutes the entire agreement between the user and AXYS with respect to the AXYS Web Site and it supersedes all prior or contemporaneous communications and proposals, whether electronic, oral or written, between the user and AXYS with respect to the AXYS Web Site. A printed version of this agreement and of any notice given in electronic form shall be admissible in judicial or administrative proceedings based upon or relating to this agreement to the same extent an d subject to the same conditions as other business documents and records originally generated and maintained in printed form. It is the express wish to the parties that this agreement and all related documents be drawn up in English.

COPYRIGHT AND TRADEMARK NOTICES:

All contents of the AXYS Web Site are: Copyright 2016 by AXYS and/or its suppliers. All rights reserved.

TRADEMARKS

The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

The example companies, organizations, products, people and events depicted herein are fictitious. No association with any real company, organization, product, person, or event is intended or should be inferred.

Any rights not expressly granted herein are reserved.

NOTICES AND PROCEDURE FOR MAKING CLAIMS OF COPYRIGHT INFRINGEMENT

Pursuant to Title 17, United States Code, Section 512(c)(2), notifications of claimed copyright infringement under United States copyright law should be sent to Service Provider’s Designated Agent. ALL INQUIRIES NOT RELEVANT TO THE FOLLOWING PROCEDURE WILL RECEIVE NO RESPONSE. See Notice and Procedure for Making Claims of Copyright Infringement.

2016-09-19T17:11:24-04:00

Committees

AXYS has four standing committees that oversee key aspects of its business, funding and other affairs. They are comprised of Board of Directors members and others who are not current directors. If you are interested in serving on any of these committees or would like to contact AXYS about a topic germane to their respective duties, please contact us

Finance and Governance Committee

The Finance and Governance Committee is responsible for making financial, liability and governance recommendations to the Board of Directors, including but not limited to interpreting and recommending changes to the bylaws, reviewing and developing policies, identifying investment policies, providing financial and insurance liability review and oversight, reviewing the audit, ensuring adequate accountability oversight, conducting nominations and elections, and orientating new board members.

Chairperson: TBA

Program Committee Charter

The Program Committee is responsible for overseeing AXYS’s current programs of support, education and membership; assessing gaps in the programs we currently provide; and envisioning new programs to meet these unmet needs.

Chairperson: TBA

Fundraising Committee

The Fundraising Committee’s principal focus is to recommend fundraising goals and strategies to the board, and either to implement them or to recommend the specific process of implementation.

Acting Chair: TBA

Research Committee

The Research Committee’s charter is to identify and propel the research goals of importance to the populations served by AXYS.  The committee suggests AXYS’s broad research agenda, identifies available resources and, through a designated board liaison, prioritizes these goals through an iterative dialogue with the AXYS’s Scientific Advisory Committee (SAC).

Chairperson:  TBA

2025-03-10T16:48:56-04:00
Go to Top